BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysis. 1983

M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure.
July 1990, Journal of internal medicine,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
[Tuberculosis in patients with chronic renal failure undergoing hemodialysis].
October 2001, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis.
May 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
[Pharmacokinetics of propranolol in patients with chronic renal insufficiency undergoing hemodialysis].
January 1979, Therapie,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis.
October 1983, Antimicrobial agents and chemotherapy,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
February 1981, Antimicrobial agents and chemotherapy,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
[Pharmacokinetics of cisplatin and vindesine in a patient with chronic renal failure undergoing hemodialysis].
September 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Nail disorders in patients with chronic renal failure undergoing hemodialysis.
January 2010, Anais brasileiros de dermatologia,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Salivary function in patients with chronic renal failure undergoing hemodialysis.
April 2002, Annals of nuclear medicine,
M S Hirsch, and N E Tolkoff-Rubin, and A P Kelly, and R H Rubin
Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis.
April 1986, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!